Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 06.01.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 366,80 360 | 366,80 | 360 | 1,853871 | BARCLAYS | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 366,80 350 | 366,80 | 350 | 4,580153 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 366,80 390 | 366,80 | 390 | 6,324973 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 366,80 400 | 366,80 | 400 | 9,051254 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 366,80 400 | 366,80 | 400 | 9,051254 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 366,80 360 | 366,80 | 360 | 1,853871 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 366,80 350 | 366,80 | 350 | 4,580153 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 475 | 366,80 | 475 | 29,498364 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 366,80 350 | 366,80 | 350 | 4,580153 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 475 | 366,80 | 475 | 29,498364 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 366,80 295 | 366,80 | 295 | 19,5747 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 366,80 295 | 366,80 | 295 | 19,5747 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 366,80 350 | 366,80 | 350 | 4,580153 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 366,80 352 | 366,80 | 352 | 4,034896 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 366,80 400 | 366,80 | 400 | 9,051254 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 366,80 295 | 366,80 | 295 | 19,5747 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 366,80 270 | 366,80 | 270 | 26,390403 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 366,80 375 | 366,80 | 375 | 2,235551 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 366,80 315 | 366,80 | 315 | 14,122137 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 475 | 366,80 | 475 | 29,498364 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 366,80 353 | 366,80 | 353 | 3,762268 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 475 | 366,80 | 475 | 29,498364 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 366,80 290 | 366,80 | 290 | 20,937841 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 366,80 375 | 366,80 | 375 | 2,235551 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 366,80 391 | 366,80 | 391 | 6,597601 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 366,80 | 366,80 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 366,80 315 | 366,80 | 315 | 14,122137 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 366,80 400 | 366,80 | 400 | 9,051254 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 475 | 366,80 | 475 | 29,498364 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 366,80 | 366,80 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 366,80 315 | 366,80 | 315 | 14,122137 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 366,80 315 | 366,80 | 315 | 14,122137 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 366,80 391 | 366,80 | 391 | 6,597601 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 366,80 290 | 366,80 | 290 | 20,937841 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 366,80 290 | 366,80 | 290 | 20,937841 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 366,80 315 | 366,80 | 315 | 14,122137 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 366,80 290 | 366,80 | 290 | 20,937841 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 20.10.2025 0 Monate | 20.10.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 17.10.2025 12 Monate | 17.10.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 16.10.2025 0 Monate | 16.10.2025 | 0 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 12 Monate | 10.10.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.10.2025 0 Monate | 10.10.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 09.10.2025 0 Monate | 09.10.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 06.10.2025 12 Monate | 06.10.2025 | 12 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.10.2025 0 Monate | 03.10.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 30.09.2025 12 Monate | 30.09.2025 | 12 Monate | 366,80 392 | 366,80 | 392 | 6,870229 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.09.2025 12 Monate | 29.09.2025 | 12 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 22.09.2025 0 Monate | 22.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 18.09.2025 0 Monate | 18.09.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.09.2025 12 Monate | 18.09.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 17.09.2025 0 Monate | 17.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 16.09.2025 0 Monate | 16.09.2025 | 0 Monate | 366,80 425 | 366,80 | 425 | 15,866957 | BERENBERG | ||
| Novo Nordisk AS | 15.09.2025 12 Monate | 15.09.2025 | 12 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 15.09.2025 0 Monate | 15.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 11.09.2025 12 Monate | 11.09.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 10.09.2025 0 Monate | 10.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 08.09.2025 12 Monate | 08.09.2025 | 12 Monate | 366,80 540 | 366,80 | 540 | 47,219193 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.09.2025 0 Monate | 05.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 03.09.2025 0 Monate | 03.09.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 01.09.2025 0 Monate | 01.09.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 29.08.2025 12 Monate | 29.08.2025 | 12 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.08.2025 12 Monate | 26.08.2025 | 12 Monate | 366,80 620 | 366,80 | 620 | 69,029444 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.08.2025 12 Monate | 21.08.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 18.08.2025 0 Monate | 18.08.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.08.2025 12 Monate | 18.08.2025 | 12 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 11.08.2025 0 Monate | 11.08.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 08.08.2025 12 Monate | 08.08.2025 | 12 Monate | 366,80 | 366,80 | -- | DZ BANK | |||
| Novo Nordisk AS | 08.08.2025 0 Monate | 08.08.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 08.08.2025 0 Monate | 08.08.2025 | 0 Monate | 366,80 620 | 366,80 | 620 | 69,029444 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 12 Monate | 07.08.2025 | 12 Monate | 366,80 600 | 366,80 | 600 | 63,576881 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 0 Monate | 07.08.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 07.08.2025 0 Monate | 07.08.2025 | 0 Monate | 366,80 620 | 366,80 | 620 | 69,029444 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 07.08.2025 12 Monate | 07.08.2025 | 12 Monate | 366,80 392 | 366,80 | 392 | 6,870229 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN | ||
| Novo Nordisk AS | 06.08.2025 0 Monate | 06.08.2025 | 0 Monate | 366,80 415 | 366,80 | 415 | 13,140676 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.08.2025 12 Monate | 04.08.2025 | 12 Monate | 366,80 400 | 366,80 | 400 | 9,051254 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.08.2025 0 Monate | 04.08.2025 | 0 Monate | 366,80 340 | 366,80 | 340 | 7,306434 | UBS | ||
| Novo Nordisk AS | 01.08.2025 12 Monate | 01.08.2025 | 12 Monate | 366,80 620 | 366,80 | 620 | 69,029444 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 30.07.2025 0 Monate | 30.07.2025 | 0 Monate | 366,80 500 | 366,80 | 500 | 36,314068 | JPMORGAN |
News
Aktuell
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M